N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44% Market Closed
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
NewGLab Pharma Co Ltd

There are no price targets for NewGLab Pharma Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
NewGLab Pharma Co Ltd Competitors:
Price Targets
002362
Hanwang Technology Co Ltd
23% Upside
TDY
Teledyne Technologies Inc
16% Upside
6845
Azbil Corp
17% Upside
NOVT
Novanta Inc
18% Upside
APT
Apator SA
29% Upside
QES
QES Group Bhd
38% Upside
688686
OPT Machine Vision Tech Co Ltd
20% Downside

Revenue
Forecast

Revenue Estimate
NewGLab Pharma Co Ltd

For the last 8 years the compound annual growth rate for NewGLab Pharma Co Ltd's revenue is -20%. The projected CAGR for the next 8 years is 26%.

-20%
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
NewGLab Pharma Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
NewGLab Pharma Co Ltd

For the last 8 years the compound annual growth rate for NewGLab Pharma Co Ltd's net income is -6%. The projected CAGR for the next 8 years is 9%.

-6%
Past Growth
9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NewGLab Pharma Co Ltd's stock price target?
Not Available

NewGLab Pharma Co Ltd doesn't have any price targets made by Wall Street professionals.

What is NewGLab Pharma Co Ltd's Revenue forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for NewGLab Pharma Co Ltd's revenue is -20%. The projected CAGR for the next 8 years is 26%.

What is NewGLab Pharma Co Ltd's Net Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for NewGLab Pharma Co Ltd's net income is -6%. The projected CAGR for the next 8 years is 9%.

Back to Top